Form SC 13G/A HOOKIPA Pharma Inc. Filed by: EcoR1 Capital, LLC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
HOOKIPA Pharma Inc. (HOOK) PT Lowered to $48 at RBC Capital
November 15, 2024 6:32 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on HOOKIPA Pharma Inc. (NASDAQ: HOOK) to $48.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "With enrollment wrapped up in the ph.II portion of the ongoing OL study... More
